Sign up to save your podcastsEmail addressPasswordRegisterOrContinue with GoogleAlready have an account? Log in here.
December 05, 2017Paul G. Richardson, MD: DEBATE: MRD, Ready for Primetime? - ConWebcast: Lymphoma and Myeloma 2017: An International Congress on Hematologic Malignancies14 minPlay
December 05, 2017Joseph R. Mikhael MD, MEd, FRCPC: Anti CD38 and anti SLAMF7 Therapeutics: Are they ready to go upfront?Webcast: Lymphoma and Myeloma 2017: An International Congress on Hematologic Malignancies19 minPlay
December 05, 2017Adam D. Cohen, MD: The future in multiple myeloma: BiTE immunotherapy, CAR-T, and immune checkpoint inhibitorsWebcast: Lymphoma and Myeloma 2017: An International Congress on Hematologic Malignancies22 minPlay
December 05, 2017Adriana C. Rossi, MD: Precursor disorders and smoldering myeloma: Are they curable?Webcast: Lymphoma and Myeloma 2017: An International Congress on Hematologic Malignancies18 minPlay
December 05, 2017Ajai Chari, MD: DEBATE: Which initial therapy for younger fit patients is best? - KRD and VRDWebcast: Lymphoma and Myeloma 2017: An International Congress on Hematologic Malignancies10 minPlay
December 05, 2017Joseph R. Mikhael MD, MEd, FRCPC: DEBATE: Which initial therapy for younger fit patients is best? - CyBord and BiRdWebcast: Lymphoma and Myeloma 2017: An International Congress on Hematologic Malignancies15 minPlay
December 05, 2017Phillipe Moreau, MD: DEBATE: One size fits all? Should everyone eligible get upfront autologous SCT - ProWebcast: Lymphoma and Myeloma 2017: An International Congress on Hematologic Malignancies15 minPlay
December 05, 2017James R. Berenson, MD: DEBATE: One size fits all? Should everyone eligible get upfront autologous SCT - ConWebcast: Lymphoma and Myeloma 2017: An International Congress on Hematologic Malignancies12 minPlay
December 05, 2017Tomer M. Mark, MD, MSc: IMid plus monoclonal antibody?Webcast: Lymphoma and Myeloma 2017: An International Congress on Hematologic Malignancies14 minPlay
December 05, 2017Sagar Lonial, MD: Targeting tumor protein 53 (p53): Is there anything we can do therapeutically?Webcast: Lymphoma and Myeloma 2017: An International Congress on Hematologic Malignancies18 minPlay